Phibro Animal Health (PAHC) Profit After Tax Growth (1y) (2013 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Profit After Tax Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 15.11% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | -5.04% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 390.91% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 26.05% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 265.56% |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -14.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.05% |
| Mar 31, 2026 | 15.06% |
| Dec 31, 2025 | 456.42% |
| Sep 30, 2025 | 364.81% |
| Jun 30, 2025 | 2,190.43% |
| Mar 31, 2025 | 148.42% |
| Dec 31, 2024 | -380.12% |
| Sep 30, 2024 | 240.89% |
| Jun 30, 2024 | -91.26% |
| Mar 31, 2024 | -16.30% |
| Dec 31, 2023 | -75.99% |
| Sep 30, 2023 | -190.09% |
| Jun 30, 2023 | 28.70% |
| Mar 31, 2023 | -43.23% |
| Dec 31, 2022 | -3.47% |
| Sep 30, 2022 | 1,521.43% |
| Jun 30, 2022 | -55.26% |
| Mar 31, 2022 | 45.46% |
| Dec 31, 2021 | -56.95% |
| Sep 30, 2021 | -104.28% |